Eyevensys
Joon is a VP at Korea Investment Partners (KIP), the largest Venture Capital in South Korea. Since joining KIP in 2017, he has been investing in healthcare – life science innovations around the world, including the US, France, UK, Belgium, Sweden, and Australia. He is currently managing 14+ portfolio companies in therapeutics and digital healthcare. He received his B.A. in Economics from University of California, Berkeley.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Eyevensys
Eyevensys is a clinical stage, private, biotechnology company developing its innovative EyeCET platform to enable the sustained intraocular production of therapeutic proteins to treat a broad range of ophthalmic disease.